Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Solventum Corporation (SOLV) Cash Flow Statement

Solventum Corporation (SOLV) generated $209.0M of operating cash flow over the twelve months to 2026-06-30, spent $327.0M on capital expenditure and had free cash flow of -$118.0M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

SOLVSolventum CorporationFollow SOLV — free
Medical Instruments & Supplies · Healthcare
—
Price chart with a free account
Market cap
14.5B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days
LineFY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow1.921.190.370.21
Capital expenditure0.290.380.38-0.33
Free cash flow1.630.81-0.01-0.12
Stock-based compensation0.040.110.16—

USD billions · SEC XBRL

Solventum Corporation — questions

What is Solventum Corporation's operating cash flow?
$209.0M over the twelve months to 2026-06-30.
How much does Solventum Corporation spend on capital expenditure?
$327.0M over the twelve months to 2026-06-30.
What is Solventum Corporation's free cash flow?
-$118.0M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from Solventum Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.